When a Child Tests Positive for Autoimmunity: How Parents Cope With Uncertainty

Researchers wanted to understand how parents feel when their infant is screened for Type 1 diabetes risk and then monitored for signs of autoimmunity. The study followed families enrolled in POInT (Primary Oral Insulin Trial), a prevention study that enrolls at-risk babies between 4 and 7 months of age. Participating parents completed anxiety questionnaires at several points—when their children were 8-11 months old, at 18 months, and at 3 years old. At each visit, babies had blood tests to check for islet autoantibodies, proteins that signal the immune system is beginning to attack the insulin-producing cells of the pancreas.

Before results even came back, parental anxiety was striking: 58.5% of mothers and 41.9% of fathers reported high Type 1 diabetes-related anxiety when their infant was between 8 and 11 months old. This suggests that simply knowing your child is at genetic risk—even before any autoantibodies appear—creates substantial worry for many families. Mothers reported higher anxiety levels than fathers at this early stage.

The anxiety picture shifted dramatically when parents learned their child's autoantibody status. For parents whose children tested negative for autoantibodies, anxiety gradually decreased as time went on and negative tests continued. But for parents who learned their child had developed autoantibodies—an indication that autoimmunity to the pancreas had begun—anxiety spiked. Even more concerning, these elevated stress levels did not improve over the following months and years; anxious parents of autoantibody-positive children remained significantly worried at all later time points measured in the study.

Certain factors made parental anxiety more likely. Parents who had a first-degree relative (parent, sibling, or child) with Type 1 diabetes reported higher anxiety than parents from the general population without that family history. Where families lived also mattered—parents in Poland and Belgium showed different anxiety patterns than other countries, though the study abstract does not specify exactly how. Interestingly, parents who felt satisfied with their involvement in the research study and felt well-supported by the research team reported lower anxiety levels, suggesting that the quality of communication and care around screening and monitoring plays a real role in family stress.

Learning your child has islet autoantibodies does not mean they will definitely develop Type 1 diabetes—some children with autoantibodies never progress to clinical disease. However, the diagnosis creates new uncertainty that parents must live with. This study underscores that genetic screening and autoantibody testing, while valuable for research and early detection, come with a genuine emotional cost. The findings suggest that better support systems, clearer communication from research teams, and acknowledgment of parental stress may help families navigate the waiting and monitoring that comes with being at-risk for Type 1 diabetes.

Source: Hormone research in paediatrics. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.